Table 2 Weighted prevalence of the target comorbidities separated by dementia status for those aged 75 and above living in the community for CFAS I and CFAS II. See methods for description of weights
Dementia | No dementia | |||||
|---|---|---|---|---|---|---|
Health condition | n | Weighted % | 95% CI | n | Weighted % | 95% CI |
CFAS I 10-year follow-up (n = 1619) | ||||||
Stroke | 17 | 22.6 | 14.0–34.4 | 143 | 9.7 | 8.3–11.4 |
Diabetes | 13 | 15.6 | 6.6–34.8 | 139 | 8.6 | 7.3–10.1 |
Visual impairment | 19 | 21.7 | 13.5–32.9 | 159 | 11.4 | 9.7–13.2 |
Target comorbidities | 41 | 47.6 | 36.5–58.8 | 375 | 25.4 | 23.2–27.7 |
CFAS II baseline (n = 3805) | ||||||
Stroke | 47 | 17.9 | 13.3–23.8 | 330 | 9.7 | 8.8–10.8 |
Diabetes | 42 | 16.2 | 11.8–21.9 | 498 | 14.3 | 13.2–15.6 |
Visual impairment | 39 | 16.7 | 12.1–22.6 | 563 | 17.3 | 16.0–18.7 |
Target comorbidities | 100 | 35.7 | 29.7–42.1 | 1194 | 35.1 | 33.5–36.8 |